Lipid Expert and Babraham Institute Director Michael Wakelam Dies

Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Babraham Institute Director Michael Wakelam died on March 31 due to respiratory complications from a suspected COVID-19 infection, according to the Babraham Institute. He was 64 years old.

Over the course of his research career, Wakelam investigated cell signaling and communication with a focus on the physiological functions of lipids, according to the Babraham Institute, where he had served as director since 2007. His lab pioneered high-sensitivity liquid chromatography-mass spectrometry (LC-MS) technology that allowed researchers to measure lipid levels in different types of cells, tissues, and tumors, and sought to understand the role that lipids play in cell function during the process of aging.

Wakelam earned an undergraduate degree in medical biochemistry in 1977 and a PhD in biochemistry in 1980, both from the University of Birmingham, according to the Babraham Institute. He then completed postdocs at the University of Konstanz in Germany and Imperial College London. In 1985, Wakelam ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Amy Schleunes

    A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours